Position in ARDX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$0
-$1,102,000 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
3 quarters on record
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Derivatives in ARDX
reported options exposure · as of Mar 31, 2026CallValue
$898,500
CallShares
150,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Stonepine Capital Management, LLC holds $317,990,358 across 56 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RADX |
Radiopharm Theranostics Ltd
|
51,000,000 | $219,300,000 | |
| 2 | VSTM |
Verastem, Inc.
|
3,302,300 | $17,502,190 | |
| 3 | TENX |
Tenax Therapeutics, Inc.
|
975,200 | $15,593,448 | |
| 4 | ADMA |
Adma Biologics, Inc.
|
740,000 | $6,667,400 | |
| 5 | CAMP |
Camp4 Therapeutics Corp
|
1,389,622 | $6,128,233 | |
| 6 | NKTR |
Nektar Therapeutics
|
85,000 | $6,115,750 | |
| 7 | ZVRA |
Zevra Therapeutics, Inc.
|
480,000 | $4,473,600 | |
| 8 | CRBP |
Corbus Pharmaceuticals Holdings, Inc.
|
383,462 | $3,600,708 |
All Filings in ARDX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $898,500 | 150,000 | Call | Sole | 2026-05-14 | |
| 2025-09-30 | $1,102,000 | 200,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,175,600 | 555,000 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||